Lexaria Bioscience LEXX SEC Filings

NASDAQ LEXX
$6.60 -2.77 (-29.56%)
At close: Sep 9, 2026 · 4:00 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Lexaria Bioscience Corp. (LEXX) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index